Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asami Shimbo

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Cytokine|June 25, 2023
Clinical significance of serum cytokine profiles for differentiating between Kawasaki disease and its mimickersShuya Kaneko, Masaki Shimizu, Asami Shimbo, et al.
Rheumatology (Oxford, England)|June 21, 2021
Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rashYuki Ichimura, Risa Konishi, Miwako Shobo, et al.
The Journal of Dermatology|December 30, 2021
Reliability of antinuclear matrix protein 2 antibody assays in idiopathic inflammatory myopathies is dependent on target protein propertiesYuki Ichimura, Risa Konishi, Miwako Shobo, et al.
Clinical Immunology (Orlando, Fla.)|July 20, 2024
Pathogenic role and diagnostic utility of interferon-α in histiocytic necrotizing lymphadenitisShuya Kaneko, Asami Shimbo, Hitoshi Irabu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 8, 2025
Serum cytokine profiling differentiates underlying diseases in cytokine storm syndromeShuya Kaneko, Maho Hatano, Asami Shimbo, et al.
Frontiers in Immunology|June 27, 2025
Clinical characteristics and treatment strategies for A20 haploinsufficiency in Japan: a national epidemiological surveyMayuka Shiraki, Saori Kadowaki, Yuki Miwa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2024
Clinical Characteristics of Cryopyrin-Associated Periodic Syndrome and Long-Term Real-World Efficacy and Tolerability of Canakinumab in Japan: Results of a Nationwide SurveyTakayuki Miyamoto, Kazushi Izawa, Sho Masui, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Cytokine|June 25, 2023
Clinical significance of serum cytokine profiles for differentiating between Kawasaki disease and its mimickersShuya Kaneko, Masaki Shimizu, Asami Shimbo, et al.
Rheumatology (Oxford, England)|June 21, 2021
Anti-nuclear matrix protein 2 antibody-positive inflammatory myopathies represent extensive myositis without dermatomyositis-specific rashYuki Ichimura, Risa Konishi, Miwako Shobo, et al.
The Journal of Dermatology|December 30, 2021
Reliability of antinuclear matrix protein 2 antibody assays in idiopathic inflammatory myopathies is dependent on target protein propertiesYuki Ichimura, Risa Konishi, Miwako Shobo, et al.
Clinical Immunology (Orlando, Fla.)|July 20, 2024
Pathogenic role and diagnostic utility of interferon-α in histiocytic necrotizing lymphadenitisShuya Kaneko, Asami Shimbo, Hitoshi Irabu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 8, 2025
Serum cytokine profiling differentiates underlying diseases in cytokine storm syndromeShuya Kaneko, Maho Hatano, Asami Shimbo, et al.
Frontiers in Immunology|June 27, 2025
Clinical characteristics and treatment strategies for A20 haploinsufficiency in Japan: a national epidemiological surveyMayuka Shiraki, Saori Kadowaki, Yuki Miwa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 25, 2024
Clinical Characteristics of Cryopyrin-Associated Periodic Syndrome and Long-Term Real-World Efficacy and Tolerability of Canakinumab in Japan: Results of a Nationwide SurveyTakayuki Miyamoto, Kazushi Izawa, Sho Masui, et al.
Pageof 3